Page last updated: 2024-08-24

ferric citrate and CKD-MBD

ferric citrate has been researched along with CKD-MBD in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Allen, MR; Avin, KG; Biruete, A; Chen, NX; Clinkenbeard, EL; Metzger, CE; Moe, SM; O'Neill, K; Srinivasan, S; Stacy, AJ; Swallow, EA; Vrabec, C	1
Anraku, M; Fukagawa, M; Imafuku, T; Ishima, Y; Itoh, K; Kadowaki, D; Maeda, H; Maruyama, T; Matsushita, K; Miyamura, S; Okuda, T; Otagiri, M; Tanaka, M; Tominaga, Y; Watanabe, H; Yamasaki, K	1
Dwyer, J; Greene, T; Korbet, S; Koury, M; Lewis, J; Shapiro, W; Sika, M; Sinsakul, M; Smith, M	1

Trials

1 trial(s) available for ferric citrate and CKD-MBD

Article	Year
The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients. Nephron. Clinical practice, 2012, Volume: 121, Issue:1-2 Topics: Adult; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Color; Constipation; Feces; Female; Ferric Compounds; Ferritins; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Renal Dialysis; Surveys and Questionnaires	2012

Article

Year

The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients.

Nephron. Clinical practice, 2012, Volume: 121, Issue:1-2

Topics: Adult; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Color; Constipation; Feces; Female; Ferric Compounds; Ferritins; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Renal Dialysis; Surveys and Questionnaires

2012

Other Studies

2 other study(ies) available for ferric citrate and CKD-MBD

Article	Year
Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2022, 09-22, Volume: 37, Issue:10 Topics: Animals; Biomarkers; Chronic Kidney Disease-Mineral and Bone Disorder; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factors; Homeostasis; Iron; Male; Minerals; Parathyroid Hormone; Phosphorus; Rats; Renal Insufficiency, Chronic; Transferrins	2022
Effect of a Ferric Citrate Formulation, a Phosphate Binder, on Oxidative Stress in Chronic Kidney Diseases-Mineral and Bone Disorder Patients Receiving Hemodialysis: A Pilot Study. Biological & pharmaceutical bulletin, 2016, Volume: 39, Issue:6 Topics: Administration, Oral; Aged; Aged, 80 and over; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Ferric Compounds; Ferritins; Humans; Male; Middle Aged; Oxidative Stress; Phosphates; Phosphorus; Renal Dialysis	2016

Article

Year

Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2022, 09-22, Volume: 37, Issue:10

Topics: Animals; Biomarkers; Chronic Kidney Disease-Mineral and Bone Disorder; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factors; Homeostasis; Iron; Male; Minerals; Parathyroid Hormone; Phosphorus; Rats; Renal Insufficiency, Chronic; Transferrins

2022

Effect of a Ferric Citrate Formulation, a Phosphate Binder, on Oxidative Stress in Chronic Kidney Diseases-Mineral and Bone Disorder Patients Receiving Hemodialysis: A Pilot Study.

Biological & pharmaceutical bulletin, 2016, Volume: 39, Issue:6

Topics: Administration, Oral; Aged; Aged, 80 and over; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Ferric Compounds; Ferritins; Humans; Male; Middle Aged; Oxidative Stress; Phosphates; Phosphorus; Renal Dialysis

2016